2kry
From Proteopedia
(Difference between revisions)
m (Protected "2kry" [edit=sysop:move=sysop]) |
|||
Line 1: | Line 1: | ||
- | + | ==Solution structure of the human mitochondrial tRNAMet ASL containing the 5-formylcytidine modification in position 34== | |
- | + | <StructureSection load='2kry' size='340' side='right' caption='[[2kry]], [[NMR_Ensembles_of_Models | 10 NMR models]]' scene=''> | |
- | + | == Structural highlights == | |
- | + | <table><tr><td colspan='2'>[[2kry]] is a 1 chain structure. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2KRY OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=2KRY FirstGlance]. <br> | |
- | + | </td></tr><tr id='NonStdRes'><td class="sblockLbl"><b>[[Non-Standard_Residue|NonStd Res:]]</b></td><td class="sblockDat"><scene name='pdbligand=PSU:PSEUDOURIDINE-5-MONOPHOSPHATE'>PSU</scene>, <scene name='pdbligand=RSQ:5-FORMYLCYTIDINE+5-(DIHYDROGEN+PHOSPHATE)'>RSQ</scene></td></tr> | |
- | + | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[2krz|2krz]], [[2krw|2krw]], [[2krv|2krv]], [[2krq|2krq]], [[2krp|2krp]]</td></tr> | |
- | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=2kry FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2kry OCA], [http://www.rcsb.org/pdb/explore.do?structureId=2kry RCSB], [http://www.ebi.ac.uk/pdbsum/2kry PDBsum]</span></td></tr> | |
- | + | </table> | |
- | == | + | __TOC__ |
- | [[2kry]] is a 1 chain structure. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2KRY OCA]. | + | </StructureSection> |
[[Category: Agris, P F.]] | [[Category: Agris, P F.]] | ||
[[Category: Bilbille, Y.]] | [[Category: Bilbille, Y.]] |
Revision as of 15:30, 12 October 2014
Solution structure of the human mitochondrial tRNAMet ASL containing the 5-formylcytidine modification in position 34
|
Categories: Agris, P F. | Bilbille, Y. | 5-formylcytidine | Asl | Modification | Rna | Trna